scPharmaceuticals (SCPH) IPO Opens Fractionally Higher

Today's IPO scPharmaceuticals Inc. (NASDAQ: SCPH) opened for trading at $14.25 after pricing 6,400,000 shares of common stock at a public offering price of $14.00 per share.

In addition, the Company has granted the underwriters a 30-day option to purchase up to 960,000 additional shares of common stock at the initial public offering price, less the underwriting discount.

Jefferies, Leerink Partners and BMO Capital Markets are acting as joint book-running managers for the offering.

scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that have the potential to transform the way therapy is delivered, advance patient care and reduce healthcare costs. Our proprietary platform is designed to enable the subcutaneous administration of therapies that have previously been limited to intravenous (IV) delivery.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• SpaceX prices IPO at $135 per share for June 12 Nasdaq debut
• Spacex IPO Retail Orders Are Said To Increase To Over $100b - Bloomberg